WebbNPI Number NPI Type Taxonomy Description for individuals Provider First Name Provider Last Name for organizations Organization Name (LBN, DBA, Former LBN or Other Name) Authorized Official First Name Authorized Official Last Name City Country Postal Code Address Type Note: The NPI Registry limits searches to the first 2100 results. Webb5 feb. 2024 · February 8, 2024 updated by: Rajwanth Veluswamy, Icahn School of Medicine at Mount Sinai. A Phase1/2a Study of Rigosertib Plus Nivolumab in Stage IV Lung Adenocarcinoma Patients With KRAS Mutation Who Progressed on First-Line Treatment.
Rajwanth Veluswamy, MD in New York, NY - Medicare Medical …
WebbRajwanth Veluswamy: Gender: Male: Speciality: Medical Oncology: Experience: 16 Years: Location: 10 E 102nd St, New York, New York: Accepts Medicare Assignments: Yes. He … WebbRajwanth R. Veluswamy, MD, MSCR, is an Assistant Professor of Medicine, Hematology and Medical Oncology, and a board certified medical oncologist who specializes in the … cortland area chamber
Dr. Rajwanth Veluswamy, MD - Healthgrades
Webb1470 Madison Ave 3rd Fl, New York, NY, 10029 (646) 835-2517 Book Online OVERVIEW Rajwanth R. Veluswamy, MD, MSCR, is an Assistant Professor of Medicine, Hematology and Medical Oncology, and a... WebbRajwanth Veluswamy is a registered Medicare physician with speciality in MEDICAL ONCOLOGY. ... Doctor Name Speciality Address; Theodore Kim: MEDICAL ONCOLOGY: ANCHORAGE, AK, 995086904: Mary Klix: ... Click on Doctor's name to get detail information including NPI and PAC ID, Affiliated Hospitals, ... WebbTwo of the responders had STK11 co-mutations and low PD-L1 expression at diagnosis. Conclusions Combination of Rigosertib and Nivolumab is safe, well tolerated and has shown early efficacy for the treatment of KRAS mutated NSCLC patients with prior progression on ICI. Clinical trial identification NCT04263090. Editorial acknowledgement cortland archery